50 Participants Needed
Massachusetts General Hospital logo

Supportive Care Intervention for Brain Cancer

Recruiting in Boston (>99 mi)
DA
Overseen ByDeborah A Forst, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on providing support and information, so it's unlikely that medication changes are required.

What data supports the effectiveness of the treatment Information and Support Intervention, NeuroPathways Intervention, Information and Support Intervention for Brain Tumor Patients?

Research shows that providing tailored information and support can help brain cancer patients and their caregivers feel more informed and supported, which can improve their overall experience and satisfaction with care. Similar approaches have been effective in meeting the supportive care needs of patients with other types of cancer, like breast cancer, by providing education and psychological support.12345

Is the Supportive Care Intervention for Brain Cancer safe for humans?

The available research does not provide specific safety data for the Supportive Care Intervention for Brain Cancer or its related interventions. However, the studies suggest that participants generally found the interventions helpful and were satisfied with them, indicating no major safety concerns were reported.16789

How is the I-CoPE supportive care treatment for brain cancer different from other treatments?

The I-CoPE treatment is unique because it focuses on structured supportive care for people with high-grade glioma and their family carers, involving staged information, regular needs screening, communication, and family engagement, rather than direct medical intervention.310111213

Research Team

Dr. Deborah A. Forst, MD | Boston, MA ...

Deborah Forst, MD

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

This trial is for adults over 18 who are patients at Massachusetts General Hospital Cancer Center, recently diagnosed (within 6 weeks) with a primary malignant brain tumor and can speak and read English. It's not suitable for those unable to consent due to severe cognitive issues or if their oncologist thinks it's inappropriate.

Inclusion Criteria

I was diagnosed with a brain tumor less than 6 weeks ago.
Massachusetts General Hospital Cancer Center patient
Able to speak and read in English
See 1 more

Exclusion Criteria

Deemed inappropriate to approach by patient's oncologist or study PI
I am able to understand and consent to participate in the study.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive an intervention guide and participate in four weekly or biweekly individual sessions with a clinician.

8 weeks
4 sessions (in-person or virtual)

Follow-up

Participants are monitored for psychological, behavioral, and cognitive outcomes, and complete surveys at baseline, 8 weeks, and 12 weeks.

4 weeks
3 survey points

Open-label extension (optional)

Participants may continue to receive supportive care and participate in exit interviews.

Long-term

Treatment Details

Interventions

  • Information and Support Intervention
Trial OverviewThe study tests an information and support intervention designed to help brain tumor patients cope. It includes access to an info guide and one-on-one coaching sessions, assessing feasibility and acceptability through surveys and exit interviews.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: NeuroPathways Pilot RCTExperimental Treatment1 Intervention
Enrolled patients will receive an intervention guide with information about navigating life with a brain tumor diagnosis, and will participate in four weekly or biweekly, individual sessions with a clinician (e.g. nurse or behavioral health specialist). Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks.
Group II: NeuroPathways Open PilotExperimental Treatment1 Intervention
Enrolled patients will receive an intervention guide with information about navigating life with a brain tumor diagnosis, and will participate in four weekly or biweekly, individual sessions with a clinician (e.g. nurse or behavioral health specialist). Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks, as well as an exit interview after the intervention.
Group III: Usual supportive careActive Control1 Intervention
Participants will receive usual supportive care, which includes referral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician. Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Findings from Research

A systematic review of 12 studies on adults with malignant cerebral glioma revealed that patient awareness of their prognosis varied, with relatives generally being more informed.
Patients and their families highly valued individualized communication and specialist nurse support, indicating a need for tailored information and care strategies, although no specific studies on effective communication interventions for this group were found.
Communication, information and support for adults with malignant cerebral glioma : a systematic literature review.Davies, E., Higginson, IJ.[2022]
A study involving 80 Taiwanese women newly diagnosed with breast cancer showed that education and psychological support significantly reduced symptom distress and unmet supportive care needs at 1 and 3 months post-surgery compared to routine care.
Participants receiving the intervention also experienced significantly lower levels of state anxiety at both 1 and 3 months after surgery, highlighting the importance of ongoing psychological support for cancer patients.
Education and psychological support meet the supportive care needs of Taiwanese women three months after surgery for newly diagnosed breast cancer: a non-randomised quasi-experimental study.Liao, MN., Chen, SC., Lin, YC., et al.[2018]
Out of 113 studies on psychosocial care for brain cancer, most focused on a single component of care, with 77% of patient-reported and 71% of support person-reported studies assessing only one aspect.
Only 24% of studies included both patient and support person perspectives, highlighting a need for more comprehensive research that evaluates multiple components of care to improve psychosocial outcomes.
Brain cancer patient and support persons' experiences of psychosocial care: a mapping of research outputs.Boyd, LAP., Waller, AE., Hill, D., et al.[2021]

References

Communication, information and support for adults with malignant cerebral glioma : a systematic literature review. [2022]
Education and psychological support meet the supportive care needs of Taiwanese women three months after surgery for newly diagnosed breast cancer: a non-randomised quasi-experimental study. [2018]
Brain cancer patient and support persons' experiences of psychosocial care: a mapping of research outputs. [2021]
Informational needs of brain metastases patients and their caregivers. [2022]
Systematic review of interventions to improve the provision of information for adults with primary brain tumors and their caregivers. [2022]
Addressing a critical need for caregiver support in neuro-oncology: development of a caregiver navigation intervention using eSNAP social resource visualization. [2022]
Childhood brain tumors: parental concerns and stressors by phase of illness. [2017]
Information needs and requirements in patients with brain tumours and their relatives. [2019]
Coping with cancer: the impact of the Cancer Information Service on patients and significant others. Part 6. [2007]
10.United Statespubmed.ncbi.nlm.nih.gov
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Implementing a Primary Healthcare Framework: The Importance of Nursing Leadership in Developing and Maintaining a Brain Tumor Support Group. [2017]
I-CoPE: A pilot study of structured supportive care delivery to people with newly diagnosed high-grade glioma and their carers. [2022]
Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. [2022]